Icu Medical (ICUI) Liabilities and Shareholders Equity (2009 - 2026)

Icu Medical has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $4.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 4.08% year-over-year to $4.0 billion; the trailing twelve-month figure through Mar 2026 stood at $16.3 billion (down 4.16% YoY), and the FY2025 full-year result was $4.1 billion, down 3.65% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $4.0 billion, down from $4.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $4.7 billion in Q1 2022, with the low at $4.0 billion in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $4.3 billion across 5 years, with a median of $4.3 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 168.9% — and 2023, when it slipped 5.82%.
• Icu Medical's Liabilities and Shareholders Equity stood at $4.5 billion in 2022, then declined by 3.04% to $4.4 billion in 2023, then declined by 3.99% to $4.2 billion in 2024, then fell by 3.65% to $4.1 billion in 2025, then declined by 0.91% to $4.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $4.0 billion (Q1 2026), $4.1 billion (Q4 2025), and $4.1 billion (Q3 2025), per Business Quant data.